Advertisement
Screener

Enavate Sciences GP, LLC Historic Quarter Change: Foreign Preferred Shares, Sold Out

Enavate Sciences GP, LLC historic quarter change: Foreign Preferred Shares, Sold out

In preferred shares (depositary receipts and foreign shares traded over the counter), over 6 quarters from 2024-12-31 to 2026-06-30, Enavate Sciences GP, LLC opened 0 positions, added to 0, reduced 0 and sold out of 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1953107), 6 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2024-12-31.

No position of this class changed this way in the filings compared.

Similar Firms

Firm NameCountry13F ValueHoldings
HTG Investment Advisors, Inc.United States$0.352B85
Cypress Capital, LLCUnited States$0.351B95
Vision Retirement, LLCUnited States$0.352B649
COLTON GROOME FINANCIAL ADVISORS, LLCUnited States$0.351B137
Alaethes Wealth, LLCUnited States$0.351B124
Trinity Financial Advisors LLCUnited States$0.351B89
ACORN CAPITAL ADVISORS, LLCUnited States$0.352B22
Brown Miller Wealth Management, LLCUnited States$0.352B270
PCJ Investment Counsel Ltd.Canada$0.352B59
Legacy Wealth Management, LLC / MSUnited States$0.351B106